Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-007283

10% owner bought 2,000 shares at $12.00 ($24,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2021-03-30 Purchase +2,000 $12.00 $24,000 4,804,544 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $12.00 · $24,000
Loading xslF345X03/doc1.xml…